Merck KGaA (OTCMKTS:MKGAF – Get Free Report) was down 6.8% on Thursday . The stock traded as low as $134.9420 and last traded at $134.9430. Approximately 817 shares were traded during mid-day trading, a decline of 7% from the average daily volume of 878 shares. The stock had previously closed at $144.8350.
Merck KGaA Stock Down 1.5%
The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market cap of $18.44 billion, a PE ratio of 21.79 and a beta of 0.96. The stock has a fifty day moving average price of $134.63 and a 200-day moving average price of $131.87.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Further Reading
- Five stocks we like better than Merck KGaA
- What is a Dividend King?
- The Nuclear Revival Is Real: SMR Stocks Flash Buy Signals After DOE Push
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Boeing’s Bullish Breakout: Is This Rally Cleared for Takeoff?
- The Basics of Support and Resistance
- Wolfspeed Just Got a $698 Million Lifeline—Here’s Why That Changes Everything
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
